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ABSTRACT
Organ transplantation is a field entangled with ethical complexities. One of the major 
controversies subject to debate is resource allocation. The UK’s organ procurement 
agency, NHS Blood and Transplant, must ensure that the limited number of human 
organs are allocated to the most efficient, yet the most deserving, transplant 
candidates. NHSBT have published numerous organ allocation protocols to this 
end, but little of known of the transplant candidate assessment process, which not 
only plays a pivotal role in selecting suitable transplant candidates for the waiting 
list, but also plays host to some of the most difficult ethical decisions in medicine. 
This piece will examine the UK liver transplant candidate assessment process in 
detail, paying particular attention to the composition of transplant teams, the diverse 
candidate criteria under examination, and the controversial grounds upon which a 
candidate can be excluded from transplantation. The limited regulations surrounding 
transplant teams and the opportunities to discriminate against particularly vulnerable 
candidates—such as alcoholics and illicit drug users—will also be discussed, and 
it will be asked if a fair assessment process for all liver transplant candidates can 
be guaranteed by NHSBT when transplant teams are subject to such a wealth of 
discretion.
INTRODUCTION
As the UK’s organ procurement agency, NHS Blood and 
Transplant’s key role is to ensure that organs donated for transplant 
are matched and allocated to patients in a fair and unbiased way.1 In 
recent years NHSBT and the Department of Health have published 
several liver allocation protocols and describe a candidate’s level 
of urgency, his blood type, and his position in the Liver Allocation 
Sequence as key liver allocation criteria.2 Although NHSBT’s 
current protocols are not without their ethical difficulties, they do 
provide clear and measurable allocation strategies which encourage 
transparency and build trust between the organ procurement agency 
and its current (and prospective) transplant candidates.
Candidate assessment occurs much earlier in the transplantation 
process and remains largely hidden from view. The scarcity of human 
organs puts considerable pressure upon organ procurement agencies 
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to allocate livers efficiently, and a strict assessment process may 
be the only feasible means of reducing the number of unsuitable 
candidates put forward for transplantation. During the last six years, 
NHSBT and the Department of Health have taken steps to standardise 
the assessment process for liver transplant candidates through the 
publication of three brief assessment guidelines,3 but these guides 
provide little in the way of calculable assessment criteria against 
which to accurately assess a candidate’s physical, psychological, 
motivational, environmental, financial and social characteristics. 
There are also no safeguards in place to protect against prejudiced 
assessment decisions, there are only limited options for redress if 
a candidate feels he has been unjustly excluded from life-saving 
treatment, and it is not clear how closely NHSBT governs transplant 
teams and the liver transplant candidate assessment process. A number 
of controversial questions therefore remain unanswered. 
What follows is a detailed examination of the current liver 
transplant candidate assessment guidelines in the UK and a discussion 
as to whether the current system can offer a fair and impartial 
assessment process for particularly vulnerable liver transplant 
candidates. A ‘universal’ assessment strategy will be suggested by 
way of conclusion to pave the way for much-needed reform.
THE DEPARTMENT OF HEALTH
In 2005 the Department of Health published the National Liver 
Transplant Standards. This brief document supports NHS Blood 
and Transplant’s professional practice by recommending diagnostic, 
assessment, allocation, transplantation, training and development 
strategies. The National Standards focus particularly on the composition 
of transplant teams and their primary objectives, which are to ensure 
that candidates who need a transplant are listed for a suitable liver 
whilst they are fit enough to survive the operation, but not so early 
that they are exposed to the risks of a transplant prematurely.4 It is 
left up to NHSBT to incorporate the following Standards into their 
own assessment guidelines at their discretion.
(i) The National Liver Transplant Standards
The National Standards begin by explaining how the assessment 
process can encourage efficient organ allocation: 
There are far more patients than there are donor organs, thus the 
process of assessment is one of making the most appropriate allocation 
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of a scarce resource. Based upon the principle that donor livers should 
be placed according to greatest benefit, it is currently recommended 
that organs should be allocated to candidates who have at least 50% 
chance of surviving five years post transplant.5 
This suggestion by the Department of Health does two things: it 
recommends that considerations of utility should underpin all liver 
allocations, and it indicates that the primary objective of candidate 
assessment is to filter out those candidates who possess only a small 
chance of short-term survival. Creating fair assessment guidelines to 
reflect these objectives is a task allocated to NHSBT.
Section 2 of the National Standards describes in detail the 
suggested composition of a transplant team: 
The liver transplant team should include: a) liver transplant surgeons, 
hepatologists, anaesthetists and critical care specialists; b) transplant 
nurses and recipient coordinators; c) a dietician, pharmacist, physio-
therapist, psychiatric liaison nurse, social worker, and chaplain; 
and d) clinicians involved in liver radiology, histopathology and 
microbiology.6 
The structure of a transplant team may therefore be adjusted to meet 
the needs of the candidate, and each transplant team will adopt a 
unique approach to assessment depending on the share of specialists. 
The Department of Health have assured with this recommendation 
that particularly vulnerable candidates will receive the appropriate 
social and psychological care for their liver disease, but could a 
personalised approach to assessment work against a candidate who 
has contributed to his own liver failure? For example, a substance-
abusing candidate may be placed with a largely social transplant team, 
who will be keen to observe, counsel and rehabilitate the candidate. 
This may include a detailed examination of the candidate’s criminal, 
social and environmental issues. A candidate in this position may feel 
‘condemned’ by his team before he’s had an opportunity to change 
his behaviour and more likely to be prohibited from transplantation 
on account of his harmful social conduct. Not only might NHSBT 
use this flexibility to their advantage to compile transplant teams who 
will be reluctant to forward ‘inefficient’ candidates for transplantation, 
but the Department of Health does not appear to regulate this process: 
standard 2.1 includes the term ‘should include…’, meaning that the 
decision as to who assesses a candidate and whether that candidate’s 
transplant team will be socially, clinically or psychologically minded 
is left up to NHSBT to regulate at their discretion.
Further information is provided in the National Standards 
about the psychiatric liaison nurse, who is particularly important to 
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candidate assessment as she will deal with the most controversial liver 
transplant cases (including alcoholic, drug-dependant and mentally ill 
candidates):
The transplant team should include a psychiatric liaison nurse, 
experienced in the management of candidates who abuse alcohol and 
drugs; and responsible for the assessment and counselling of candidates 
with alcohol or drug abuse problems as well as other candidates with 
psychiatric problems.7 
The Department of Health shows considerable compassion and 
support for a fairer assessment process in this recommendation by 
allowing for an experienced substance abuse specialist to assess these 
candidates in an open-minded and understanding way. However, 
despite the fact that the psychiatric nurse retains one of the most 
ethically contentious jobs in candidate assessment, the Department of 
Health has provided no further assessment guidelines to show the nurse 
how to implement a fair assessment of alcoholic, drug-dependant and 
mentally ill candidates. The National Standards do assert that: ‘there 
should be written Guidelines and Protocols of Care for candidates 
undergoing assessment’,8 but it appears that full discretion is handed 
to NHSBT to develop these protocols. 
Section 3 of the National Standards is all about candidate 
assessment. The following recommendations are put forward by 
the Department of Health for the assessment of all liver transplant 
candidates: 
Candidates should be assessed by a multidisciplinary team; assessment 
should be based as far as possible on objective criteria and should 
include a detailed review of the candidates’ physical and psychological 
condition to determine whether transplantation is indicated as treatment 
for their liver disease and whether they are sufficiently fit to have a 
reasonable chance of long term survival; candidates with generally 
accepted contraindications (e.g. those who continue to abuse alcohol) 
should not be offered transplantation.9 
These recommendations are curious in that they encourage objective 
assessment with a twist. The Department of Health are encouraging 
objectivity by focusing on a candidate’s physical and psychological 
condition to ascertain his fitness levels, survival rate and suitability 
for the procedure. These considerations require little in the way 
of social assessment and will simply distinguish candidates on 
clinical grounds. However, the final recommendation that patients 
with ‘generally accepted contraindications’ should not be offered 
transplantation at all could lead to a rather blinkered elimination 
process. What exactly is a ‘contraindication’ and what makes 
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contraindications ‘generally accepted’? With regards to candidates 
who continue to abuse alcohol, does this recommendation include 
recovering alcoholics, or just candidates who abuse alcohol during 
the assessment process? If it is the latter, are they excluded for 
clinical reasons, or on grounds of efficiency? The Department of 
Health fails to define ‘contraindications’ to transplantation (i.e. the 
grounds for outright rejection) or provide any guidelines as to how 
contraindications should be calculated, allowing NHSBT to draft their 
own ‘generally accepted’ exclusion criteria (examined in detail below). 
The Department of Health is therefore sending mixed messages in its 
recommendations. Should the candidate assessment process support a 
blanket ban upon particular groups of candidates? If not, what form 
should contraindications to transplantation take? The result is that 
NHSBT is under significant pressure to define and implement an 
ethical version of these recommendations.
The Department of Health give alcoholic candidates a particularly 
difficult time throughout the National Standards, making it clear 
where they stand on alcoholic assessment: 
It is generally accepted that candidates with alcoholic liver disease 
are likely to develop disease in their new liver if they continue to 
abuse alcohol. Such candidates are also likely to be non-compliant 
with medication and clinic visits. Candidates assessed as likely to 
continue to abuse alcohol are usually regarded as unsuitable for liver 
transplantation.10 
It is understandable that the Department of Health wish to exercise 
caution over alcoholic candidates: public support for organ donation 
is a great concern for organ procurement agencies and their governing 
bodies, and there is an expectation that NHSBT will allocate 
scarce organs to suitable and responsible candidates. However, why 
are alcoholic candidates ‘usually regarded’ as unsuitable? Is this 
assumption based on clinical reasons i.e. an accurate assessment is 
far more difficult, or is it based on grounds of efficiency or social 
aversion to alcoholic liver transplants? The rationale underpinning 
this assumption has not been made clear. If the Department of 
Health is publishing unfair social assumptions about the behaviour 
of a particular group of candidates in its National Standards, these 
suggestions could translate into a collection of prejudiced assessment 
protocols at agency-level. NHSBT must therefore ensure that they 
do not reject alcoholic or drug-dependant candidates simply because 
they are assumed to defy their post-transplant care. It may be that 
candidates who continue to abuse dangerous substances are inefficient 
choices for transplantation because they present a very high risk 
of graft failure, but any contraindications to transplantation should 
28
be clearly underpinned by these clinical calculations, not social 
or behavioural assumptions. Because NHSBT could not think to 
incorporate such partial views into any of their formal assessment 
protocols, they have displayed considerable caution when publishing 
their assessment guidelines for alcoholic and drug-dependant liver 
transplant candidates.
In terms of fair and objective candidate assessment, the 
National Liver Transplant Standards are generally disappointing. The 
Department of Health has provided little in the way of a foundation for 
NHS Blood and Transplant to develop their own impartial candidate 
assessment protocols. Efficiency emerges as a chief consideration 
for the Department of Health and this is balanced with the need to 
provide a personal assessment experience with a tailored transplant 
team, but NHSBT are in receipt of such a wealth of discretion that 
it is almost impossible to guarantee, on the basis of the Department 
of Health’s recommendations, that all liver transplant candidates 
will receive a fair and objective assessment. The ambiguity of the 
National Standards gives NHSBT maximum room to discriminate in 
the interests of utility. Is the candidate offered any form of redress 
should his experience be unsatisfactory? The Department of Health 
provides some vague directions in the event that a candidate should 
complain about his experience: 
The transplant team [may] decide that the candidate is not suitable 
for transplantation. The reasons for the decision are explained to the 
candidate, his family and carers. Candidates who disagree with the 
decision are offered the option of a second opinion at another transplant 
centre.11 
This recommendation uses an interesting choice of words. The term 
‘not suitable’ suggests that a candidate is ‘inappropriate’, and this 
can be interpreted clinically or ethically. If the term ‘not eligible’ 
was substituted, this would suggest that the candidate simply did 
not meet the necessary clinical criteria. On the point of redress, the 
candidate is encouraged by the Department of Health to go elsewhere. 
This is not really redress, as it provides little hope for the excluded 
candidate and it places no responsibility upon NHSBT to justify their 
controversial assessment decisions. 
As a result of the Department of Health’s rather ambiguous recom-
mendations, a considerable amount of direction, power and control is 
handed to NHSBT. This is reflected in their liver transplant candidate 
assessment protocols (below). With all of this in mind, it would be 
rather fitting to finish this section with National Standard 1.10: ‘staff 
in the multidisciplinary team should be trained in communication 
skills… there should be a policy for breaking bad news’.12
29
NHS BLOOD AND TRANSPLANT
NHS Blood and Transplant is responsible for the fair and 
equitable assessment of all its transplant candidates and must publish 
a whole raft of assessment protocols to ensure that this process is 
recognised and regulated. Following the Department of Health’s 
National Liver Transplant Standards in 2005, NHSBT published three 
relevant documents: general protocols for adults undergoing liver 
transplantation (2009), alcoholic candidate assessment guidelines 
(2005), and illicit drug-use assessment guidelines (2007).13 The 
general protocols from 2009 provide a brief overview of the whole 
transplantation process with a small section on assessment, whereas 
the two smaller guidelines from 2005 and 2007 are specifically 
developed to provide guide transplant teams through the assessment 
of alcoholic and drug-dependant candidates. NHSBT has the difficult 
task of ensuring that any protocols produced on the back of the 
Department of Health’s National Standards are fair yet practical. 
Does candidate assessment improve at agency-level?
(i) Protocols for Adults Undergoing Liver Transplantation (2009)
NHSBT begins its general liver transplant protocols with an 
encouraging objective: ‘livers donated for transplantation should be 
considered a national resource and therefore guidelines for their 
use needed to be agreed publicly and followed nationally’.14 This 
statement allows for candidates to feel ‘involved’ in the development 
of liver transplant protocols and it promotes a feeling of transparency. 
NHSBT can build vital public trust through the guarantee of clear, 
accessible and patient-friendly transplant guidelines.
In terms of candidate assessment, NHSBT’s 2009 protocols 
clearly outline what a typical transplant team will investigate: 
Candidates should be accepted for transplantation only if they have 
an estimated probability of being alive 5 years after transplantation of 
at least 50% with a quality of life acceptable to the candidate. Other 
medical and social factors (such as alcohol or drug misuse, age or anti-
social lifestyle) are relevant if they affect the above criteria.15 
The recommendation by the Department of Health that a candidate 
must show a 50% chance of surviving five years post transplant16 has 
been expanded considerably by NHSBT to include a controversial 
‘quality of life’ criterion and anti-social characteristics. Why has 
NHSBT chosen to add these elements and what affect does it have 
on the candidate’s chances of transplantation?
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‘Quality of life’ is a notoriously difficult factor to measure in 
clinical terms, even if it is the candidate who makes the decision. An 
‘acceptable’ quality of life is not defined by NHSBT, and a personal 
criterion such as this will inevitably vary from candidate to candidate. 
Perhaps NHSBT felt the need to incorporate the candidates’ view into 
the assessment process to allow for more vulnerable candidates to be 
considered for transplantation? Reservations have been raised in the 
past about a Quality Adjusted Life Years approach to allocating scarce 
medical resources.17 How can a transplant team accurately measure 
‘quality of life’ in a way that is fair to a candidate, yet ensures that 
no groups of candidates are met with a distinct disadvantage (i.e. all 
elderly candidates are excluded on the grounds that their quality years 
have passed)? There would be little point in allocating an organ to a 
candidate who is not expected to benefit from it or survive any longer 
than a few days, but the word ‘quality’ alludes to the measurement of 
worth, and the result of a ‘quality of life’ decision would be to label 
any inefficient, minority, frail or undesirable candidates as ‘worthless’. 
NHSBT cannot be seen to reject candidates simply because they have 
past their best.
Anti-social characteristics were briefly mentioned in the 
National Standards in the guise of alcoholism. NHSBT has inevitably 
incorporated anti-social characteristics into its 2009 protocols (above), 
but according to NHSBT these factors will only be assessed if 
they affect the candidate’s 50% chance of surviving five years post 
transplant. How is it possible for a transplant team to conclusively 
prove that a candidate’s liver failure is due to his or her anti-social 
behaviour? Some cases may be obvious (such as alcohol-induced 
liver disease) but other cases may be less clear (such as heavy drug 
use coinciding with unexpected liver failure). Additionally, just how 
many anti-social factors can a transplant team attribute to liver failure? 
NHSBT has provided further details regarding the assessment of non-
medical factors in section 3 of its 2009 protocols: 
Other factors which will need to be considered will include the reason 
which gave rise to the primary cause of liver failure (for example, 
alcohol-induced liver diseases); a history of illegal drug use or of self-
inflicted, medical or psychiatric conditions; and the patient’s age.18 
NHSBT have widened the Department of Health’s ‘five year’ recom-
mendation significantly to allow for further social, psychological, 
environmental, criminal and self-inflicted conditions to be in-
corporated into the assessment process. For the purposes of efficient 
liver allocation, a meticulous approach to assessment is logical: it 
will guarantee that the most efficient candidates are selected for 
transplantation and it will ensure that those who have caused their 
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own liver failure through self-inflicted alcohol and drug abuse will 
not be forwarded for a liver transplant. However, these guidelines 
are woolly. Transplant teams have no definitive standard against 
which to measure the gravity of these non-medical factors in a way 
that is fair and consistent. An investigation into the real cause of 
a candidate’s liver failure will also be an uncomfortable experience 
for many candidates, feeling as though they are being subjected to 
a rigorous personal examination and judged solely in light of their 
unhealthy lifestyle choices. NHSBT does not expressly state that any 
non-medical factors are a complete contraindication to transplantation, 
but they make it clear that a candidate’s reckless behaviour is open 
to scrutiny by the transplant team. 
Alcoholism is one anti-social factor that causes particular concern 
for organ procurement agencies. A candidate who continues to abuse 
alcohol will not only put his new liver at risk, but he will be placed 
in direct competition with other liver transplant candidates who have 
not caused their own liver failure. This moral issue generates great 
public anxiety. 19 The Department of Health were quite clear in the 
National Standards when it came to the assessment of alcoholics: 
alcoholism is a ‘generally accepted’ contraindication and should be a 
barrier to transplantation.20 NHSBT have showed considerable caution 
when re-drafting this recommendation into their 2009 protocols. 
In an attempt to avert any apparent prejudice, NHSBT present the 
following alcohol assessment policy: 
A multi-disciplinary approach is required to select candidates who are 
likely to comply with follow-up schedules and not return to a damaging 
pattern of alcohol consumption after transplantation and may include 
psychological/psychiatric assessment.21 
NHSBT have moved away from the postulation that all alcoholics 
should be automatically excluded from liver transplantation and 
instead suggest that alcoholic candidates should be subject to a 
detailed social and psychiatric assessment. In the National Standards, 
this task is allocated to an experienced psychiatric liaison nurse to 
allow for a tailored assessment experience. Perhaps NHSBT believe 
that a multi-disciplinary transplant team would be better suited to 
dealing with such complex individuals? This is more beneficial for 
particularly vulnerable candidates: a nurse may focus only on social 
issues, whereas a well-rounded team will place more emphasis on 
medical utility.
Frustratingly, NHS Blood and Transplant have come no further 
forward in providing clear assessment regulations for transplant 
teams when incorporating the Department of Health’s ambiguous 
National Standards into its assessment protocols. The ‘quality of life’ 
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criterion simply adds a new ethical complication to the assessment 
process which may be especially problematic for a small handful 
of candidates who transplant teams consider to possess an already 
substandard quality of life.
NHSBT has, however, made a direct move to embrace all 
candidates with all kinds of problems into the assessment process, 
including alcoholic, drug-dependant, self-inflicting and mentally-ill 
candidates. With this compassionate undertaking comes a responsibility 
to develop detailed and comprehensive assessment guidelines to 
ensure that every candidate receives an objective and consistent 
assessment experience, but transplant teams still appear to possess 
complete discretion as to how, and against what criteria, candidates 
are assessed. When a candidate’s lifestyle choices, attitudes, criminal 
history, environment, habits and motivations are exposed under the 
microscope for detailed scrutiny, NHSBT cannot currently guarantee 
that the outcome will be impartial because transplant teams have no 
definitive benchmarks against which to consistently measure these 
non-medical factors. Transplant teams may argue that these meticulous 
examinations are crucial for economical reasons, but judgments 
regarding a candidate’s anti-social behaviour will creep into murky 
territory. Another issue arising from the 2009 protocols which will 
be a particular concern for candidates is who do transplant teams 
answer to if it emerges that a candidate’s exclusion is based on social 
or behavioural grounds? Perhaps the Department of Health could step 
in?
NHSBT has taken further steps to support the assessment 
of alcoholic and drug-dependant candidates. Further assessment 
guidelines published in 2005 and 2007 allow for transplant teams to 
employ a far more tailored (and far more critical) assessment strategy 
for these difficult candidates, which are outside of the ambit of the 
National Standards. It is not clear why these additional guidelines 
have been created, although public pressure to allocate livers sensibly 
may have exerted a strong influence. 
(ii) Recommendations for liver transplant assessment of alcohol-
dependant candidates (2005)
In 2005, the Liver Advisory Group (LAG) published assessment 
guidelines for candidates with alcohol-related liver disease.22 NHS 
Blood and Transplant have endorsed these guidelines to combat the 
potential risk of recurrent disease and poor compliance leading to 
graft loss, and recommend that transplant teams employ a careful 
assessment of psychosocial and substance use factors for candidates 
with a diagnosis of alcohol-related liver disease.23 The guidelines are 
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brief, but they contain various contraindications to listing (i.e. grounds 
for exclusion to transplantation) and are intended to work alongside 
NHSBT’s 2009 liver transplant protocols (above) to enhance liver 
transplant success rates. 
The Liver Advisory Group (in conjunction with NHSBT) begin 
the 2005 alcoholic guidelines by suggesting that any alcoholic 
candidate assessment should include a careful attention to risk 
factors associated with predicting a relapse to drinking.24 Calculating 
a candidate’s risk of relapse is incredibly difficult and may require 
a detailed psychological examination to uncover the candidates’ 
personal reasons for becoming alcohol-dependant. Unfortunately, 
‘risk factors’ are not defined by the guidelines, but it is anticipated 
that they will include any social, criminal, emotional, psychological, 
employment, financial and physical factors which may influence a 
candidate during his waiting period and beyond. Without a scale of 
reference in place to accurately measure these factors, a transplant 
team are potentially free to initiate a comprehensive investigation into 
a candidate’s private life. This will be extremely uncomfortable for 
many candidates, and may expose areas of his or her life that have 
no impact of graft success (such as a previous criminal conviction). 
With these concerns in mind, the Liver Advisory Group admit that 
the use of specific factors to predict a relapse is not appropriate 
because of weak evidence, and that further research is required to 
identify factors that can reliably predict a poor outcome in terms of 
graft function and survival.25 However, the Liver Advisory Group still 
remind transplant teams that: 
Robust criteria for predicting a return to heavy drinking and its 
consequences on graft function must: i) discriminate consistently and 
be clinically meaningful; ii) be objective and measureable; iii) be fair; 
iv) cannot be, or likely to be, modified.26 
If risk factors must be reliable to provide an accurate prediction of 
relapse, should transplant teams be left with only a vague framework 
with which to create their own assessment criteria? Perhaps the 
likelihood of relapse should not be assessed until reliable risk factors 
can be provided by an endorsing body? The Liver Advisory Group 
do not provide any more guidance on alcoholic candidate assessment, 
preferring to focus on contraindications instead (below). These 
assessment criteria are therefore disappointingly vague considering 
their objective to combat the potential risk of recurrent disease or 
poor compliance leading to graft loss. It is also extremely difficult to 
identify any other factors that are ‘clinically meaningful, objective, 
measureable, fair and cannot be modified’ other than a candidate’s 
age and blood type. How do transplant teams ensure that their 
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assessments of alcoholic candidates are consistent, fair and clinically 
meaningful when they have no clear, objective, calculable risk factors 
at hand when assessing the candidate? The good news, incorporated 
from the Department of Health’s National Standards, is that candidates 
admitted for assessment where alcohol has contributed to their liver 
disease will be assessed by a specialist in substance misuse.27 This 
will ensure a more understanding and compassionate assessment 
experience, but candidates may still fear that their transplant teams 
will find it relatively easy to ‘predict’ a relapse on little medical 
evidence. 
The four contraindications to transplantation are interesting. It 
was agreed by the Liver Advisory Group that there were several 
factors, each of which precluded listing for a transplant, because 
a poor outcome for the graft was likely.28 It is encouraging to see 
utility as the primary reason for excluding alcoholic candidates from 
transplantation as opposed to social or moral reasons, although this 
does not provide much hope for gravely ill, minority, elderly or non-
rehabilitated candidates. 
The first contraindication to transplantation is alcoholic hepatitis, 
which does not cause any significant ethical problems. The second 
contraindication to transplantation is more than two episodes of non-
compliance with medical care where there was not a satisfactory 
explanation, but this should not be confined to management of their 
liver disease.29 This is a strange request from the Liver Advisory Group. 
It appears that a candidate’s medical history may be meticulously 
examined for non-compliance to any medical treatment. Is it fair 
to exclude a candidate from transplantation on the grounds that he 
did not comply to unrelated medical care in the past? Admittedly, 
any past non-compliance may help a transplant team to shed some 
light on a candidate’s motivation levels, but to request a ‘satisfactory 
explanation’ is particularly pretentious. Perhaps it would be better to 
simply consider a candidate’s past non-compliance rather than asking 
the candidate to justify his bad behaviour like a naughty school-
child? This could lead to NHSBT ‘punishing’ the candidate by 
excluding him from life-saving treatment. The third contraindication 
to transplantation is a return to drinking following full professional 
assessment and advice (this includes permanent removal from the list 
if found to be drinking while listed).30 From a clinical point of view, 
this ground for exclusion is justified; abstinence from alcohol whilst 
awaiting a liver transplant is vital as it allows the candidate to detoxify 
his body; it enables a more successful graft, and it demonstrates the 
candidate’s motivation and dedication towards his post-transplant care. 
From an ethical point of view however, by permanently excluding 
from transplantation a candidate who is found to be drinking whilst 
on the waiting list, are NHSBT again seeking to punish candidates 
35
for their socially unacceptable behaviour? Why permanent removal? 
Perhaps it might be more rehabilitative to place relapsing candidates 
on a ‘pending’ waiting list, or monitored over time in accordance 
with a long-term approach to assessment?
The fourth and final contraindication to transplantation is 
concurrent or consecutive illicit drug use (except occasional cannabis 
use).31 It is interesting that only highly dangerous illegal drugs—such 
as heroin or cocaine—are viewed as contraindications. Cannabis 
use is known to cause high blood pressure, paranoia, panic attacks 
and loss of co-ordination in users32 and may also connect to social, 
environmental, financial, employment and criminal justice issues. Why 
has the Liver Advisory Group made allowances for cannabis use? 
It may be that candidates who abuse highly dangerous substances 
such as heroin are assumed to be more likely to display anti-social 
behaviour and not comply with post-transplant care, but there are no 
reliable clinical indicators to support this assumption.
The Liver Advisory Group/NHSBT may have made matters a 
little more difficult with their 2005 alcoholic guidelines. In order 
to combat the risk of recurrent disease, poor compliance and graft 
loss they have listed four seemingly clinical contraindications to 
transplantation, but these contraindications simply encourage a highly 
subjective and meticulous examination of a candidate’s personal and 
social life. Social prejudices appear to be scattered throughout the 
alcoholic contraindications with NHSBT seeking to strictly punish 
(i.e. permanently exclude) candidates who have not behaved in an 
acceptable way, and because the Department of Health played no part 
in developing these additional guidelines, NHSBT are free from strict 
supervision or radical reform.33 As a result, transplant teams seem free 
to exclude difficult candidates from transplantation on ambiguous and 
undetermined grounds, and the recommendation that their decision 
must be ‘clinically meaningful, objective, measurable and fair’ means 
little when no further guidelines are provided to guarantee a more 
consistent assessment strategy. Primary concerns centre around 
contraindications two (permanent exclusion failing a satisfactory 
explanation for past non-compliance) and three (permanent exclusion 
for drinking whilst listed), which encourage transplant teams to 
take a heavy-handed approach to candidates who are still perfectly 
suitable for a graft as long as they remain abstinent for a set amount 
of time and can prove to the substance abuse specialist that they are 
dedicated to their post-transplant care. Additional concerns relate to 
the lack of consistent decisions and the wealth of discretion awarded 
to transplant teams when assessing such personal matters. Reliable 
and detailed standards would make it exceptionally difficult for a 
transplant teams’ biased views (or the views of a particular specialist) 
to be incorporated into the candidate assessment process.
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However, there is some good news for candidates in the form 
of redress for unwelcome decisions: ‘if a possible recipient is found 
by the multi-disciplinary team not to be a suitable candidate then 
the opportunity for a second opinion from a second liver transplant 
unit should be offered’.34 This may only provide limited hope for a 
candidate who feels he or she has been discriminated against and it 
will have no regulatory affect on the conduct of transplant teams, but 
it does illustrate a desire on the part of NHSBT to accommodate as 
many candidates as possible. 
(iii) Recommendations for liver transplant assessment of  
candidates who use illicit drugs (2007)
In 2007, the Liver Advisory Group published further assessment 
guidelines for liver transplant candidates who were involved in illicit 
drug use.35 These guidelines, compared to the alcohol guidelines 
of 2005, are much more painstaking when assessing a candidate’s 
personal circumstances. There may be three explanations for this: 
(a) illicit drug use is highly damaging to the liver; (b) it may reveal 
problems with the candidate’s state of mind; and (c) the general 
public may not condone their donated organs to be allocated to illicit 
drug users. What is also unique about the 2007 drug guidelines is 
that contraindications to transplantation are followed by potential 
contraindications to transplantation, as if to make doubly-sure that a 
candidate’s circumstances are meticulously scrutinised.
The 2007 drug guidelines begin with a clear direction from the 
Liver Advisory Group to transplant teams that no stone should be left 
unturned when assessing illicit drug using candidates: 
Any candidate considered to have a significant drug taking history 
should be assessed by a specialist in substance misuse. The term 
‘significant’ must be interpreted by the clinical, multi-disciplinary 
team. Assessment should include problematic or dependant use as well 
as recent use. It should also identify substance use and stability within 
the candidate’s wider social support network, and take into account 
mental health and criminal justice issues as appropriate.36 
It becomes clear from this direction that the assessment of drug 
using candidates will involve much wider psychological and social 
considerations than those of other candidates. The ‘stability’ of the 
candidate’s social circle is a particularly unusual criterion to measure 
to ascertain whether a candidate can successfully undergo a medical 
procedure, and the examination of criminal justice issues will be an 
uncomfortable leap out of the ambit of medicine for some candidates. 
37
The 2007 drug guidelines may therefore make a small handful of 
candidates feel very vulnerable to biased decisions.
The 2007 drug guidelines list five contraindications to trans-
plantation. The first contraindication recommends that candidates 
who display ongoing intravenous use of illicit or non-prescribed 
substances will be excluded from the waiting list.37 Interestingly, in 
NHS Blood and Transplant’s 2009 liver transplant protocols (based 
on the Department of Health’s National Liver Transplant Standards), 
continued intravenous drug use is listed a contraindication to 
transplantation owing to the possible risk of infection in a immune-
suppressed candidate,38 but there is no indication in the 2007 drug 
guidelines that this contraindication is underpinned by a clinical 
ideology. Is this merely an oversight by the Liver Advisory Group, 
or do they believe that all contraindications to transplantation in 
drug abuse assessment guidelines will be accepted as correct without 
the need for clinical justification? Perhaps NHSBT could make 
it clearer that any assessment guidelines adopted for the use of 
assessing drug using candidates are based on medical grounds? The 
second contraindication is similar to the 2005 alcohol guidelines in 
that a candidate who shows two or more incidents within 2 years 
of unexplained and significant non-compliance with treatment not 
necessarily confined to the management of liver disease will be 
excluded from transplantation.39 As explained earlier, this alludes to 
NHSBT ‘punishing’—through exclusion from life-saving treatment—
candidates who can not justify their non-compliant behaviour.
Contraindications 3 and 4 are unique to the 2007 drug guidelines 
and require: 
A current failure to comply with the assessment and treatment process 
for transplantation, refusal to provide consent for gaining access to 
information pertaining to drug treatment and prescribing, and a recent 
past history of cross dependency (substituting from one drug to harmful/
problematic use of another), within the last 2 years.40 
The Liver Advisory Group advance a rather biased view in this 
contraindication: (a) illicit drug users will not comply with the 
assessment process; (b) they will not comply with the treatment 
process; and (c) they will refuse to allow the medical team to access 
their medical records. It is unusual to see patients being excluded 
from medical treatment on the grounds of their unruly behaviour, but 
it is even more unusual for a national health organisation to expressly 
presuppose that a particular group of candidates will sabotage their 
own chances of survival. Why is this contraindication applicable to 
drug using candidates but not alcoholics or mentally ill candidates? 
No clinical rationale is presented to support this contraindication 
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which would, in turn, make the contraindication applicable to other 
groups of candidates too. Perhaps one possible explanation for this 
contraindication is the public pressure exerted upon organ procurement 
agencies to allocate livers sensibly?. It also seems a little odd that a 
candidate will be excluded from transplantation if he or she switches 
from one harmful drug to another within a 2 year period. There 
seems little point in distinguishing between a candidate who abuses 
several different substances from a candidate who abuses just one. 
Apart from indicating that the former candidate may have displayed 
a lack control over his drug use in the past, it is difficult to ascertain 
how switching from one illicit drug to another can justify a further 
ground for excluding a candidate from transplantation. What must 
surely matter is the candidate’s current drug use and how that will 
affect his liver graft presently? If a candidate is a suitable clinical 
match to a donor liver, NHSBT will find it hard to argue based on 
these ‘anti-social’ grounds that they are not discriminating against 
drug using candidates when excluding them from transplantation. 
The fifth and final contraindication to transplantation states that 
the length of abstinence from illicit drugs should not be less than 
6 months, and the candidate must engage in an optimum substance 
misuse treatment programme.41 This contraindication gives candidates 
the opportunity to prove that they are dedicated towards their 
treatment, and it gives their bodies a chance to recover from the 
effects of drug use.
Uniquely, the 2007 drug guidelines include potential 
contraindications, which allow transplant teams to examine additional 
characteristics which may jeopardise a candidate’s graft success 
(this is not confirmed), but it is left up to the transplant team to 
decide whether the particular characteristic is a contraindication to 
transplantation or not. Three of the seven potential contraindications 
listed in the guidelines are particularly controversial: 
(i) insufficient social support network to remain abstinent from illicit 
drugs, and where it is not possible to work with the candidate to 
facilitate a suitable and acceptable social support package; (ii) lack 
of motivation to move away from drug using culture/area within the 
confines of opportunity; and (iii) reluctance to agree to drug treatment 
and after-care or to sign a treatment agreement.42 
In real terms, according to the Liver Advisory Group, a transplant team 
may therefore exclude a drug using candidate from transplantation if: 
(i) he does not have a supportive social group of friends; (ii) he can 
not feasibly sustain a support package in his current area; (iii) he 
does not show a desire to move into a better area; and (iv) he is 
reluctant to agree to drug treatment. These liver transplant assessment 
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guidelines are beginning to read like a drug rehabilitation programme. 
With the exception of criterion (iv), which places the onus upon the 
candidate to behave in a socially acceptable manner, criteria (i), (ii) 
and (iii) isolate the candidate’s social environment as a barrier to 
transplantation. In terms of efficiency, it is logical that the candidate 
should show dedication towards his aftercare programme and that 
he can rehabilitate himself for graft success, but to expect him to 
remove himself from his environment, culture and social circle at the 
first possible opportunity—presumably to a ‘better area’ to become a 
‘better person’—seems wholly prejudiced of NHSBT. How would a 
transplant team clinically and fairly assess these criteria in a way that 
was objective and consistent to the candidate? As long as the candidate 
abstains from his drug use six months prior to transplantation, 
shows the motivation to continue his aftercare programme and is a 
clinical match to the donor liver, all further considerations about any 
candidate’s social life and culture should not come within the ambit 
of medical assessment. 
As with the 2005 alcohol guidelines, the Liver Advisory Group/
NHSBT presents a controversial collection of guidelines which make 
more complicated an assessment process that was already fraught 
with ethical difficulties. The most problematic criteria by far in 
the 2007 drug guidelines is the examination of a candidate’s social 
circle, and in particular the ‘substance use and stability within the 
patient’s wider social support network.’ It is not practically possible 
to objectively assess this criteria in a way that clinically renders the 
candidate suitable or unsuitable for a liver transplant. Short of tracking 
down individuals who are in no way related to the transplantation and 
examining their lifestyle choices and behavioural problems, transplant 
teams are unable to consistently assess a candidate’s social network 
in a way that could fairly influence their decision. Another significant 
concern is the level of prejudice that emerges in the potential and 
actual contraindications. We again see an supposition by the Liver 
Advisory Group/NHSBT that substance abusing candidates will 
intentionally sabotage their own chances of survival through refusal, 
reluctance and non-compliance. The additional requirement that 
a drug using candidate should enjoy a sufficient social network in 
order to secure a ‘suitable and acceptable social support package’ 
is simply discriminatory. These highly subjective criteria will be a 
significant concern for drug using candidates who experience liver 
failure, whether their predicament was caused by their anti-social 
behaviour or not. Interestingly, no reference made in the 2007 drug 
guidelines to a ‘second opinion’ or any other form of redress. Is this 
merely an oversight, or are drug users simply too much of a risk for 
organ procurement agencies?
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CONCLUSION: A WAY FORWARD?
NHS Blood and Transplant must ensure that all potential transplant 
candidates are offered a fair and unbiased assessment experience. The 
Department of Health’s National Liver Transplant Standards fail to 
provide NHSBT with any firm regulatory or ethical guidance to ensure 
an impartial assessment experience for liver transplant candidates, and 
with only the ambiguous National Standards available to support the 
development of agency-level assessment protocols, NHSBT and the 
Liver Advisory Group have been free to draft most of the guidelines 
from scratch. This liberty is reflected in the assessment protocols for 
regular candidates (2009), alcoholic candidates (2005) and drug-using 
candidates (2007).
At first glance, NHSBT’s 2009 protocols are encouraging in 
that they develop the National Standards to include more candidates, 
but this initiative creates a further problem: an all-inclusive approach 
requires comprehensive assessment criteria to ensure that all candidates 
are assessed fairly, objectively and in conjunction with their special 
needs. NHSBT appears to simply hand all power to transplant 
teams to choose how, and against what criteria, all individuals are 
assessed. Depending on the cause of the candidate’s liver failure 
and the specialists assigned to his case, a candidate’s transplant 
team may therefore examine (and nominate as a contraindication to 
transplantation) the following factors: urgency, motivation, utility, 
sociology, justice, employment, equality, psychology, environment or 
morality. NHSBT can not, therefore, guarantee that when a candidate’s 
array of characteristics are placed under the microscope for a detailed 
examination, the outcome will be impartial and objective. Transplant 
teams have no definitive benchmarks against which to consistently 
measure these non-medical factors. Candidates who are gravely ill, 
elderly or self-inflicting are particularly vulnerable to the inconsistent 
decisions of ‘tailor made’ transplant teams as they present further 
ethical quandaries, and transplant teams are themselves vulnerable to 
public pressure, making strict decisions much more likely.
NHSBT has endorsed two further assessment guidelines by 
the Liver Advisory Group for the fair assessment of alcoholic and 
drug using candidates. These additional guidelines, which are meant 
to bring clarity and consistency to the assessment process, lack 
the meticulous detail required to assess complex cases. Those who 
have caused their own liver to fail through alcohol or drug abuse 
face a much more painstaking assessment process than those who 
have not, regardless of any promises of the contrary (e.g. NHSBT’s 
official website states: ‘we ensure that organs donated for transplant 
are matched and allocated to patients in a fair and unbiased way’ 
43). Alcoholic candidates face a difficult assessment process, and 
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although a second opinion at another unit is offered (which could 
vaguely resemble ‘redress’ for unfairly rejected candidates), NHSBT’s 
2005 alcohol assessment guidelines appear to mirror the Department 
of Health’s rather negative attitude towards alcoholic candidates by 
excluding them from transplantation on behavioural grounds. Drug 
using candidates face further prejudiced obstacles during assessment, 
including the examination of potential contraindications to allow 
for an even more scrupulous assessment of the candidate’s personal 
life. Not only are drug-using candidates anticipated to sabotage their 
chances of survival by refusing to provide access to medical records 
and not complying with medical care, with no method of redress listed 
for drug using candidates, the overall assessment outlook for these 
individuals is unwelcoming. NHSBT claim to distance themselves 
from prejudice by promising fair and equal access to organs, but 
the examination of a candidate’s social network is unquantifiable 
and unfair and renders particular candidates victims of their own 
social circumstances. These candidates may also resent the label of 
‘substance abuser’ (used in the 2007 guidelines), and they may feel 
condemned to months of counselling, delays and discrimination for 
their social problems before a fair assessment process can even begin. 
So what can be done?
It may be that the segregation of complex candidates is causing 
the problem: NHSBT’s current assessment guidelines are too 
ambiguous to deal with complex candidates, leading to the separation 
of alcoholic and drug using candidates from the standard assessment 
process and the development of separate assessment guidelines to deal 
with this. Perhaps a ‘universal’ assessment strategy could be created 
to apply to all liver transplant candidates, so that a patients’ drug and 
alcohol abuse could be viewed as a clinical factor in an extensive 
assessment process rather than a social problem that underpins the 
whole assessment strategy. There would then be no need to produce 
separate guidelines for specific candidates which create delays, 
alienation and prejudice. A new universal protocol would, of course, 
need to be meticulous and complex in clinical terms, allowing for 
the fair exclusion of candidates who pose a direct health risk to their 
new liver. It would also require objective and measurable assessment 
criteria to allow for the objective examination of all clinical factors 
(which could include limited access to aftercare), and there should be 
an express prohibition of the examination of social or psychological 
issues unless they would directly (i.e. clinically) cause the graft to 
fail.44 An assurance could also be provided that NHSBT will look 
into any allegations of prejudice by transplant teams. This universal 
and clinical policy would efficiently remove inefficient candidates 
from the transplantation process without publically assessing them 
separately from other candidates.
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One would have hoped that when drafting such contentious 
protocols, NHSBT would have adopted a much more meticulous 
approach to detail. This is almost inevitable when considering that 
NHSBT is under no immediate pressure from any higher authority 
to ensure that the candidate assessment process is as comprehensive 
as it should be.
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